Evidence map›Paper›PMID 34811455›Full record

ArticleScientific reports2021

Lockdowns lose one third of their impact on mobility in a month.

Yogesh V Joshi, Andres Musalem

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Nonlinear time-series forecasts for decision support: short-term demand for ICU beds in Santiago, Chile, during the 2021 COVID-19 pandemic.International transactions in operational research : a journal of The International Federation of Operational Research Societies · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yogesh V JoshiRobert H. Smith School of Business, University of Maryland, College Park, 20742, USA. yjoshi@umd.edu.
Andres MusalemDepartment of Industrial Engineering, University of Chile, Santiago, Chile.

Funding

ANID AFB180003
6 · The paper itself

Abstract

As the novel coronavirus (COVID-19) pandemic spread across the world over the past year, many countries imposed lockdowns in the form of stay at home requirements on their citizens to mitigate its spread. We analyze mobility data from 93 countries implementing lockdowns to investigate their immediate impact on mobility and the subsequent evolution of mobility. We find that at the start of a lockdown, median mobility is reduced to 36% below the baseline, and by another 18% in the subsequent 2 weeks. 70 countries had lockdowns lasting beyond 4 weeks and showed a significant reduction in mobility compared to that prior to the lockdown. Mobility was at its minimum 18 days into the lockdown for the median country. Comparing this minimum mobility to the average mobility 2 weeks before the lockdown, we observe a median reduction of 50 percentage points, evidencing that lockdowns reduce mobility. For 59 of these 70 countries, lockdowns lasted at least 4 weeks after reaching minimum mobility and most observed a significant rebound in mobility during the lockdown period. For the median country, 30.1% of the mobility reduction achieved is lost within 4 weeks, and lockdowns lose all their impact on mobility in 112.1 days. Overall, our findings show that while lockdowns significantly reduce mobility, this impact is also subject to fatigue as the lockdown period extends longer. The magnitude of mobility reductions achieved and fatigues reported in this research can help policy makers anticipate the likely impact of their lockdown policies.

Indexed as

MovementQuarantineCOVID-19FatigueHumansModels, TheoreticalTime Factors

Identifiers

PMID34811455
PMCPMC8608930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.